1-(4-ブロモフェニル)ピペラジン 臭化物

1-(4-Bromophenyl)piperazine

HCID 2735629

基本情報

CAS
66698-28-0
標準SMILES
Brc1ccc(N2CCNCC2)cc1
InChIKey
PJHPFAFEJNBIDC-UHFFFAOYSA-N
分子式
C10H13BrN2
平均分子量
241.13 g/mol
単同位体質量
240.02621052

名称と識別子

優先名称
1-(4-Bromophenyl)piperazine
IUPAC
1-(4-bromophenyl)piperazine
現地名
1-(4-ブロモフェニル)ピペラジン 臭化物
英語名
1-(4-Bromophenyl)piperazine
分子式
C10H13BrN2
分子量
241.13

名称と別名

1-(4-bromophenyl)piperazine66698-28-0Piperazine, 1-(4-bromophenyl)-4-BppRX2Y9C2G6XN-(4-Bromophenyl)piperazine1-(Para-bromophenyl)piperazineDTXSID50370841RefChem:74431DTXCID70321875663-248-4MFCD00130198
名称をさらに表示
1-(4-ブロモフェニル)ピペラジン 臭化物1-(4-ブロモフェニル)ピペラジンKML-30CML-0271-(4-Bromophenyl)1-(4-Bromophenyl)piperazine - [B93256]1-(4-BROMO-PHENYL)-PIPERAZINE DIHYDROCHLORIDE
PBPP1-(4-bromophenyl)-piperazine4-bromophenylpiperazineUNII-RX2Y9C2G6X4-(4-bromophenyl)piperazineOprea1_814607SCHEMBL15942SCHEMBL3183333

データベース識別子

CAS
66698-28-0
PubChem CID
2735629
DTXSID
DTXSID50370841
UNII
RX2Y9C2G6X
EC Number
663-248-4
Nikkaji
J1.509.774D

物性

構造計算による物性

XLogP
1.9
極性表面積
15.3 Ų
水素結合供与体数
1
水素結合受容体数
2
回転可能結合数
1
重原子数
13

物理化学的性質

融点
91 · 91-95 °C
沸点
353.3 · 353.3±27.0 °C(Predicted)
比重(密度)
1.386 · 1.386±0.06 g/cm3(Predicted)
貯蔵温度
2 · 2-8°C
外見
solid
酸解離定数(Pka)
8.88 · 8.88±0.10(Predicted)

安全と法規制

GHS分類

GHS Classification · 4 件

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P261, P264, P270, P271, P280, P301+P317, P302+P352, P304+P340, P317, P321, P330, P362+P364, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 42 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

危険有害性情報

Hazard Classes and CategoriesAcute Tox. 4 (100%)

安全データ

wgk
1
risk_code
20/21/22
hazard_code
Xi,Xn
hazard_note
Irritant
Hazard Classifications
Acute Tox. 4 DermalAcute Tox. 4 InhalationAcute Tox. 4 Oral
ストレージクラス
11 - Combustible Solids

化学と産業

応用分野 · 1 件

説明1-(4-Bromophenyl)piperazine (street names: 4-bromo-piperein, 4-BP, brein) is structurally related to 1-(4-fluorophenyl)piperazine and to 1-(4-chlorophenyl)piperazine. The only difference is the halogen substituent type attached to the phenyl ring's para-position. In the case of NPSs from the methcathinone group, which are also neurotransmitter releasers, structure–activity studies demonstrated that the replacement of a fluorine or chlorine atom with a bromine atom resulted in a compound with more potency for the release of both dopamine and serotonin. The lowest dopamine selectivity, an additional consequence of these halogen replacements, results in lower abuse potential in favor of empathogenic properties[1].

サプライヤー100 社

河北凡博医药科技有限公司15588346797
天津始加生物医药科技有限公司15022261580 · [email protected]
上海麦克林生化科技股份有限公司021-50706066 15221275939 · [email protected]
上海毕得医药科技股份有限公司400-1647117 13681763483 · [email protected]
安徽合诺生物科技有限公司0555-2761852

関連反応

53 件

化合物ノート

読み込み中…